Business Context and Reporting Period
Company: Alpha Pro Tech, Ltd.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2000
Business Overview: The Company develops, manufactures, and markets disposable protective apparel, infection control products (masks/shields), extended care products, and consumer goods (pet bedding/toys). Operations are divided into three segments: Apparel, Mask/Shield, and Extended Care. The Company is incorporated in Delaware with executive offices in Markham, Ontario, Canada.
Key Financial Metrics
| Metric | 2000 | 1999 |
|---|---|---|
| Net Sales | $21,130,000 | $20,235,000 |
| Gross Profit | $8,892,000 | $7,985,000 |
| Gross Margin | 42.1% | 39.5% |
| Net Income | $1,460,000 | $1,129,000 |
| Diluted EPS | $0.06 | $0.05 |
| Cash and Cash Equivalents | $1,131,000 | $785,000 |
| Working Capital | $5,475,000 | $4,378,000 |
| Total Debt (Notes & Leases) | $535,000 | $926,000 |
| Operating Cash Flow | $2,091,000 | $1,677,000 |
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 4.4% to a record $21.13 million, driven by growth in the Apparel (4.8%) and Mask/Shield (5.7%) segments. The Food Service market saw a 212.5% increase, though it remains a small portion of total revenue.
- Profitability: Net income rose 29.3% to $1.46 million. This was primarily due to a $907,000 increase in gross profit (margin expansion from 39.5% to 42.1%) and a reduction in net interest expense.
- Expense Management: Selling, General, and Administrative (SG&A) expenses increased 7.6% to $6.83 million, largely due to higher payroll costs ($392,000) and public company expenses ($50,000).
- Liquidity: Cash increased by $346,000. The Company reduced total borrowings by $427,000 and repurchased 374,100 shares of common stock for $506,000.
- Tax Provision: Income tax provision increased significantly to $199,000 from $18,000 as the Company utilized prior-year Net Operating Losses (NOLs) through the third quarter of 2000.
Guidance, Outlook, and Risks
- Outlook: Management expects a sixth consecutive record year for sales and net income in 2001. Gross margins are expected to remain strong due to global sourcing and manufacturing efficiencies.
- Capital Expenditures: Anticipated 2001 capital expenditures include $400,000 for mask manufacturing improvements and $150,000 for automated shoecover capabilities.
- Share Repurchase: The Board authorized an additional $500,000 share repurchase program in January 2001.
- Key Risk - Customer Concentration: Sales to VWR Scientific Products represented 62.5% of total sales in 2000. The loss of this customer would have a material adverse effect on the business. The exclusive agreement with VWR was extended through 2003 with a minimum annual purchase requirement of $12.5 million.
- Operational Risk: High order volume in late 2000 extended delivery times to 45 days; the Company anticipates returning to under 30-day delivery by Q2 2001.
Investor Verification Checklist
- VWR Dependency: Verify the stability of the exclusive distribution agreement with VWR Scientific Products, which accounts for the majority of revenue.
- Margin Sustainability: Confirm that the 42.1% gross margin is sustainable given the increase in SG&A expenses and potential raw material cost fluctuations.
- Debt Covenants: Review the terms of the $4.04 million credit facility (line of credit, term note, and equipment loan) to ensure compliance with covenants, particularly regarding asset-based borrowing limits.
- Inventory Levels: Assess the $2.4 million inventory balance against the reported decrease in inventory levels and the risk of obsolescence in the medical/consumer product sectors.
- Share Count: Monitor the impact of the ongoing share repurchase program on earnings per share and total outstanding shares (23,942,516 as of Dec 31, 2000).